Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Feb 7 2025

Full Issue

Scientists Zero In On When Cells Turn Cancerous, Devise Process To Reverse It

In a trial on colon cancer cells, researchers found that at the moment of critical transition — when cancer and normal cells coexist — they were able to flip the molecular switch that allowed normal cells to recover. Also, an early phase trial on a cancer vaccine is showing promise.

Newsweek: Scientists Discover Way To Reverse Cancer

Scientists have discovered a molecular switch that can reverse cancer—turning cancer cells back into their healthy counterparts. The revelation by researchers from the Korea Advanced Institute of Science & Technology (KAIST) in Daejeon, South Korea, could lead to new cancer treatments. (Randall, 2/6)

Stat: Personalized Cancer Vaccine Shows Potential In Kidney Cancer 

Nine patients with advanced kidney cancer who received an experimental vaccine tailored to their tumors’ specific mutations mounted an immune response to their disease and remained cancer-free for three years, an early-phase clinical trial has shown. (Cooney, 2/5)

Modern Healthcare: Mayo Clinic, Mount Sinai Push For In-Home Cancer Care

Technology and hospital-at-home programs are paving the way for in-home treatments to be the new frontier in cancer care — if reimbursement and other challenges can be worked out. Mayo Clinic, Huntsman Cancer Institute, Mount Sinai and Memorial Sloan Kettering Cancer Center are among the providers leveraging acute care at-home programs and telehealth to treat certain patients outside of traditional care settings as the number of cancer diagnoses in the U.S. climbs. But patient safety, regulatory and reimbursement challenges are obstacles to expanding in-home cancer care. (Eastabrook, 2/6)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF